The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
New-Born Screening-Global Market Insights and Sales Trends 2024
Synopsis
Most of the infants are born normal and healthy at the time of birth and with no family history of disorders . Unfortunately, once symptom appears in child, they are often irreversible leading to severe health and developmental problems. Newborn screening helps in identifying diseases, which can affect a child’s health in the long run, at an early stage. Newborn screening, which includes a series of tests, is essential for early detection, diagnosis, and management , to prevent disability and death of a child. These tests, which are performed shortly after the birth of a baby, are used for the detection of genetic, developmental, and metabolic disorders in newborn babies.
The global New-Born Screening market size is expected to reach US$ 1357.7 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of New-Born Screening in various end use industries. The expanding demands from the Hospitals, Clinics, Nursing Homes and Others, are propelling New-Born Screening market. Tandem Mass Spectrometry, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pulse Oximetry Screening Technology segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for newborn screening due to the need for reducing healthcare cost . Asia is expected to witness high growth rates in the next five years in the newborn screening market . China and India are expected to be the fastest-growing newborn screening markets in Asia Pacific. Some of the key growth drivers of the newborn screening market in emerging countries are the large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for New-Born Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global New-Born Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global New-Born Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, New-Born Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of New-Born Screening covered in this report include GE Healthcare, Trivitron Healthcare, AB Sciex, Perkinelmer, Bio-Rad Laboratories, Agilent Technologies, Medtronic, Masimo and Waters, etc.
The global New-Born Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
Global New-Born Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New-Born Screening market, Segment by Type:
Tandem Mass Spectrometry
Pulse Oximetry Screening Technology
DNA-Based Assays
Hearing Screen Technology
Others
Global New-Born Screening market, by Application
Hospitals
Clinics
Nursing Homes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of New-Born Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Most of the infants are born normal and healthy at the time of birth and with no family history of disorders . Unfortunately, once symptom appears in child, they are often irreversible leading to severe health and developmental problems. Newborn screening helps in identifying diseases, which can affect a child’s health in the long run, at an early stage. Newborn screening, which includes a series of tests, is essential for early detection, diagnosis, and management , to prevent disability and death of a child. These tests, which are performed shortly after the birth of a baby, are used for the detection of genetic, developmental, and metabolic disorders in newborn babies.
The global New-Born Screening market size is expected to reach US$ 1357.7 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of New-Born Screening in various end use industries. The expanding demands from the Hospitals, Clinics, Nursing Homes and Others, are propelling New-Born Screening market. Tandem Mass Spectrometry, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pulse Oximetry Screening Technology segment is estimated at % CAGR for the next seven-year period.
North America dominates the global market for newborn screening due to the need for reducing healthcare cost . Asia is expected to witness high growth rates in the next five years in the newborn screening market . China and India are expected to be the fastest-growing newborn screening markets in Asia Pacific. Some of the key growth drivers of the newborn screening market in emerging countries are the large pool of patients, increasing healthcare expenditure, and rising government funding and initiatives.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for New-Born Screening, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global New-Born Screening market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global New-Born Screening market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, New-Born Screening sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of New-Born Screening covered in this report include GE Healthcare, Trivitron Healthcare, AB Sciex, Perkinelmer, Bio-Rad Laboratories, Agilent Technologies, Medtronic, Masimo and Waters, etc.
The global New-Born Screening market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Trivitron Healthcare
AB Sciex
Perkinelmer
Bio-Rad Laboratories
Agilent Technologies
Medtronic
Masimo
Waters
Natus Medical
Global New-Born Screening market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global New-Born Screening market, Segment by Type:
Tandem Mass Spectrometry
Pulse Oximetry Screening Technology
DNA-Based Assays
Hearing Screen Technology
Others
Global New-Born Screening market, by Application
Hospitals
Clinics
Nursing Homes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of New-Born Screening companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of New-Born Screening
1.1 New-Born Screening Market Overview
1.1.1 New-Born Screening Product Scope
1.1.2 New-Born Screening Market Status and Outlook
1.2 Global New-Born Screening Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global New-Born Screening Market Size by Region (2018-2029)
1.4 Global New-Born Screening Historic Market Size by Region (2018-2023)
1.5 Global New-Born Screening Market Size Forecast by Region (2024-2029)
1.6 Key Regions, New-Born Screening Market Size (2018-2029)
1.6.1 North America New-Born Screening Market Size (2018-2029)
1.6.2 Europe New-Born Screening Market Size (2018-2029)
1.6.3 Asia-Pacific New-Born Screening Market Size (2018-2029)
1.6.4 Latin America New-Born Screening Market Size (2018-2029)
1.6.5 Middle East & Africa New-Born Screening Market Size (2018-2029)
2 New-Born Screening Market by Type
2.1 Introduction
2.1.1 Tandem Mass Spectrometry
2.1.2 Pulse Oximetry Screening Technology
2.1.3 DNA-Based Assays
2.1.4 Hearing Screen Technology
2.1.5 Others
2.2 Global New-Born Screening Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global New-Born Screening Historic Market Size by Type (2018-2023)
2.2.2 Global New-Born Screening Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America New-Born Screening Revenue Breakdown by Type (2018-2029)
2.3.2 Europe New-Born Screening Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific New-Born Screening Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America New-Born Screening Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa New-Born Screening Revenue Breakdown by Type (2018-2029)
3 New-Born Screening Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Nursing Homes
3.1.4 Others
3.2 Global New-Born Screening Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global New-Born Screening Historic Market Size by Application (2018-2023)
3.2.2 Global New-Born Screening Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America New-Born Screening Revenue Breakdown by Application (2018-2029)
3.3.2 Europe New-Born Screening Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific New-Born Screening Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America New-Born Screening Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa New-Born Screening Revenue Breakdown by Application (2018-2029)
4 New-Born Screening Competition Analysis by Players
4.1 Global New-Born Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in New-Born Screening as of 2022)
4.3 Date of Key Players Enter into New-Born Screening Market
4.4 Global Top Players New-Born Screening Headquarters and Area Served
4.5 Key Players New-Born Screening Product Solution and Service
4.6 Competitive Status
4.6.1 New-Born Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare New-Born Screening Products, Services and Solutions
5.1.4 GE Healthcare New-Born Screening Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Trivitron Healthcare
5.2.1 Trivitron Healthcare Profile
5.2.2 Trivitron Healthcare Main Business
5.2.3 Trivitron Healthcare New-Born Screening Products, Services and Solutions
5.2.4 Trivitron Healthcare New-Born Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Trivitron Healthcare Recent Developments
5.3 AB Sciex
5.3.1 AB Sciex Profile
5.3.2 AB Sciex Main Business
5.3.3 AB Sciex New-Born Screening Products, Services and Solutions
5.3.4 AB Sciex New-Born Screening Revenue (US$ Million) & (2018-2023)
5.3.5 Perkinelmer Recent Developments
5.4 Perkinelmer
5.4.1 Perkinelmer Profile
5.4.2 Perkinelmer Main Business
5.4.3 Perkinelmer New-Born Screening Products, Services and Solutions
5.4.4 Perkinelmer New-Born Screening Revenue (US$ Million) & (2018-2023)
5.4.5 Perkinelmer Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories New-Born Screening Products, Services and Solutions
5.5.4 Bio-Rad Laboratories New-Born Screening Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies New-Born Screening Products, Services and Solutions
5.6.4 Agilent Technologies New-Born Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic New-Born Screening Products, Services and Solutions
5.7.4 Medtronic New-Born Screening Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 Masimo
5.8.1 Masimo Profile
5.8.2 Masimo Main Business
5.8.3 Masimo New-Born Screening Products, Services and Solutions
5.8.4 Masimo New-Born Screening Revenue (US$ Million) & (2018-2023)
5.8.5 Masimo Recent Developments
5.9 Waters
5.9.1 Waters Profile
5.9.2 Waters Main Business
5.9.3 Waters New-Born Screening Products, Services and Solutions
5.9.4 Waters New-Born Screening Revenue (US$ Million) & (2018-2023)
5.9.5 Waters Recent Developments
5.10 Natus Medical
5.10.1 Natus Medical Profile
5.10.2 Natus Medical Main Business
5.10.3 Natus Medical New-Born Screening Products, Services and Solutions
5.10.4 Natus Medical New-Born Screening Revenue (US$ Million) & (2018-2023)
5.10.5 Natus Medical Recent Developments
6 North America
6.1 North America New-Born Screening Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe New-Born Screening Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific New-Born Screening Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America New-Born Screening Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa New-Born Screening Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 New-Born Screening Market Dynamics
11.1 New-Born Screening Industry Trends
11.2 New-Born Screening Market Drivers
11.3 New-Born Screening Market Challenges
11.4 New-Born Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
